Estonia Infection Control Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product (Disinfectants, Sterilization (Low-Temperature Sterilization, Heat Sterilization, Contract Sterilization)), By End User Industry (Healthcare, Food And Beverage, Chemical) - Forecasts From 2022 To 2027

The Estonia infection control market is projected to grow at a compound annual growth rate of 15.54% over the forecast period to attain a market size of US$18.038 million in 2027, from US$6.562 million in 2020. Due to a considerably greater gap between socioeconomic groups in Estonia when compared to the European Union (EU), the government of Estonia 2017 provided more sustainable funding to its highly centralized health insurance system, which is a single entity, with the potential objective of reducing to reduce fragmentation and increasing coordination. Despite a visible improvement in life expectancy since 2000 that has increased more in Estonia than in any other EU country, nearly half of all deaths in Estonia result from behavioral risks, above the EU average of 39 %. As of 2017, Estonia had the third-highest adult obesity rates after Malta and Latvia, with a significant increase in childhood obesity. Albeit the rate of smoking and drinking has declined, it has remained significantly higher than that of the EU averages.

Further, the expenditure on health care per person borne by Estonia is approximately half the EU average, to the tune of EUR 1 559, and is equivalent to 6.4 % of GDP. The health insurance system, which is a single entity, accounts for three-quarters of health spending, whereas 23.6 % is from out-of-pocket payments. Since the country relies on general practitioners and outpatient specialists to provide care, most spending covers outpatient or ambulatory services. Even though the health status of Estonian people is now nearing the EU average, mainly due to fewer deaths from ischemic heart disease and strokes, Self-reported unmet health care needs are the highest in the EU and affect individuals across various income groups. Further, in 2016, ischaemic heart disease represented one-fifth of all deaths in Estonia (3 120 deaths). To this end, it may be noted that the mortality rate from ischaemic heart disease in Estonia (252 deaths per 100 000 population) is more than twice the EU average of 118.8. With 51 deaths per 100,000 people, lung cancer is the most common cause of cancer death among Estonians and the third-highest cause of death overall. Lung cancer is the most frequent cause of death by cancer among Estonians and the third-highest cause of death overall at 51 deaths per 100 000 population.

The state and local governments mostly own hospitals in Estonia or public legal bodies. In contrast, primary care centres, pharmacies, and outpatient clinics (if not part of a hospital) are privately owned. Thus, this is another region where the state bears a substantial expenditure on health care and the private sector. Estonia's two largest hospitals, Tallinn and Tartu, account for 50 % of specialist services. Furthermore, in Estonia, 12 per 100 000 died from a heart attack, and 17 died from a stroke within 30 days of being admitted to the hospital. This is higher than the EU average [Source: OECD/European Observatory on Health Systems and Policies (2019), Estonia: Country Health Profile 2019, State of Health in the EU]. Therefore, there have been conscientious efforts from the government to provide various healthcare offerings along with a relative increase in the number of private participants.

Further, a decent portion of the population still suffers from major diseases requiring inpatient care. Further, there are also surgeries like cataracts whereby the maximum percentage of patients leave on the same day, making room for more operations. Therefore, with the prevalence of diseases, the involvement of the government and the inclusion of private players to uphold the well-being of the patients, as well as high patient turnover as exemplified by patients of cataract operations, the need for following inception prevention protocol by the healthcare segment of the country is of paramount importance. This need will drive the demand for infection prevention products during the forecast, thereby throttling the Infection Control Market's growth in Estonia during the forecast period as well.

Key Development:

• Enterprise Estonia (EAS) has prepared a list of Estonian manufacturers who currently or potentially have the ability to manufacture personal protection and disinfection equipment. The website www.eas.ee/isikukaitsevahendid presents the product range offered by Estonian companies as well as their contact details. The purpose of the website is to unite the demand and supply.
• July 2020: Liviko, an Estonia-based distiller has launched the dual-purpose vodka Travel Safe bio, a drinking vodka that can be used as a disinfectant. The product is designed for people who love to travel and it has a perfect size for travelling and staying safe, as it can also be used as a disinfectant for hands, surfaces, fruit, and vegetables.

COVID-19 SCENARIO

The worst contagious sickness the globe had seen in years struck. Because there were insufficient safeguards in place, the coronavirus infection expanded to a degree that was never anticipated or envisioned, with a portion of the spread being fueled by hospital-acquired diseases. The COVID-19 virus impacted a large number of medical personnel, and the majority of those instances were brought on by hospital environments, where contact and infections were propagated. The infection Control market was given much more attention as it became clear how serious the pandemic was, and numerous controls were put in place to prevent them. The hospital-acquired infection control equipment was in extremely high demand as a result. As the pandemic fades, demand for infection control devices in Estonia is anticipated to decline, but a growing emphasis on hospital-acquired illnesses is anticipated to keep the industry afloat at a low rate over the ensuing year.

Estonia Infection Control Market Scope:

Segmentation:

• By Product
  • Disinfectant
  • Sterilization
    • Low temperature Sterilization
    • Heat Sterilization
    • Contract Sterilization
• By End User Industry
  • Healthcare
  • Food and Beverage
  • Chemical